17-alpha-hydroxyprogesterone has been researched along with Metabolic Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Araújo, JE; Cardoso, NS; Dutra, SGV; Ferriani, RA; Gastaldi, AC; Ribeiro, VB; Souza, HCD | 1 |
| Altinok, M; Andersen, M; Buch, K; Glintborg, D; Mumm, H; Ravn, P | 1 |
2 other study(ies) available for 17-alpha-hydroxyprogesterone and Metabolic Diseases
| Article | Year |
|---|---|
Polycystic ovary syndrome associated with increased adiposity interferes with serum levels of TNF-alpha and IL-6 differently from leptin and adiponectin.
Topics: 17-alpha-Hydroxyprogesterone; Adiponectin; Adipose Tissue; Adolescent; Adult; Androgens; Biomarkers; Body Mass Index; Case-Control Studies; Female; Follicle Stimulating Hormone; Glucose; Humans; Insulin; Insulin Resistance; Interleukin-6; Leptin; Luteinizing Hormone; Metabolic Diseases; Polycystic Ovary Syndrome; Risk Factors; Sedentary Behavior; Tumor Necrosis Factor-alpha; Young Adult | 2020 |
Prolactin is associated with metabolic risk and cortisol in 1007 women with polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Biomarkers; Body Mass Index; Cholesterol; Cross-Sectional Studies; Dehydroepiandrosterone Sulfate; Estradiol; Female; Glucose Tolerance Test; Humans; Hydrocortisone; Lipoproteins, HDL; Lipoproteins, LDL; Metabolic Diseases; Polycystic Ovary Syndrome; Prolactin; Regression Analysis; Retrospective Studies; Risk Assessment; Testosterone; Triglycerides; Waist Circumference | 2014 |